Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Nihon Rinsho. Japanese Journal of Clinical Medicine|February 19, 2004
[Grouping of abnormal sexual development--guide to diagnosis]Hiroyuki OshimaPlos One|February 29, 2020
Development of Oral Care Chip, a novel device for quantitative detection of the oral microbiota associated with periodontal diseaseAi Nozawa, Hiroyuki Oshima, Naoyuki Togawa, et al.Zoological Science|July 20, 2002
Molecular cloning of a putative gastric chitinase in the toad Bufo japonicusHiroyuki Oshima, Rieko Miyazaki, Yoshihide Ohe, et al.Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology|May 29, 2002
Isolation and sequence of a novel amphibian pancreatic chitinaseHiroyuki Oshima, Rieko Miyazaki, Yoshihide Ohe, et al.Genome|April 11, 2006
Molecular cloning and chromosomal localization of the Bombyx Sex-lethal geneTeruyuki Niimi, Ken Sahara, Hiroyuki Oshima, et al.American Journal of Ophthalmology Case Reports|September 25, 2024
Disappearance of lens epithelial cells detected at the treatment of intraocular lens dislocation 12 months after cataract surgery: A case reportDaijiro Kurosaka, Kouhei Hashizume, Hiroyuki Oshima, et al.Chemical Communications (Cambridge, England)|August 3, 2017
Desorption dynamics of CO<sub>2</sub> from formate decomposition on Cu(111)Fahdzi Muttaqien, Hiroyuki Oshima, Yuji Hamamoto, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2003
Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancerTakao Kamai, Toshihiko Tsujii, Kyoko Arai, et al.Biochemical and Biophysical Research Communications|October 13, 2010
Novel GPR119 agonist AS1535907 contributes to first-phase insulin secretion in rat perfused pancreas and diabetic db/db miceShigeru Yoshida, Takahide Ohishi, Tetsuo Matsui, et al.Biochemical and Biophysical Research Communications|September 7, 2010
AS1907417, a novel GPR119 agonist, as an insulinotropic and β-cell preservative agent for the treatment of type 2 diabetesShigeru Yoshida, Hirotsugu Tanaka, Hiroyuki Oshima, et al.Pageof 2